Combination immunotherapy improves survival in mouse models of mesothelioma – Science Daily
|
Combination immunotherapy improves survival in mouse models of mesothelioma
Science Daily Combined treatment with two cancer immunotherapy drugs — one a novel immune modulator and one that focuses and activates the antitumor immune response — significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma … |
